Site icon pharmaceutical daily

All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

January 26, 2024 – Company announcement no. 1 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com Press RelationsSanne Seyer-Hansen+45 6038 6207dksash@chr-hansen.com
Attachment

No. 1 All necessary regulatory approvals have been obtained

Exit mobile version